ASND · Categories · Coverage
ASND - Analyst coverage initiated
Ascendis Pharma A/S (ASND) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for ASND
- H.C. Wainwright initiated coverage on Ascendis Pharma with a new price targetH.C. Wainwright initiated coverage of Ascendis Pharma with a rating of Buy and set a new price target of $345.00
- BMO Capital Markets initiated coverage on Ascendis Pharma with a new price targetBMO Capital Markets initiated coverage of Ascendis Pharma with a rating of Outperform and set a new price target of $319.00
- Citigroup initiated coverage on Ascendis Pharma with a new price targetCitigroup initiated coverage of Ascendis Pharma with a rating of Buy and set a new price target of $355.00
- Barclays initiated coverage on Ascendis Pharma with a new price targetBarclays initiated coverage of Ascendis Pharma with a rating of Overweight and set a new price target of $342.00
- Wolfe Research initiated coverage on Ascendis Pharma with a new price targetWolfe Research initiated coverage of Ascendis Pharma with a rating of Peer Perform and set a new price target of $255.00
- Raymond James initiated coverage on Ascendis Pharma with a new price targetRaymond James initiated coverage of Ascendis Pharma with a rating of Strong Buy and set a new price target of $271.00
- RBC Capital Mkts initiated coverage on Ascendis Pharma with a new price targetRBC Capital Mkts initiated coverage of Ascendis Pharma with a rating of Outperform and set a new price target of $205.00
- UBS initiated coverage on Ascendis Pharma with a new price targetUBS initiated coverage of Ascendis Pharma with a rating of Buy and set a new price target of $196.00
- Stifel initiated coverage on Ascendis Pharma with a new price targetStifel initiated coverage of Ascendis Pharma with a rating of Buy and set a new price target of $200.00
- Jefferies initiated coverage on Ascendis Pharma with a new price targetJefferies initiated coverage of Ascendis Pharma with a rating of Buy and set a new price target of $150.00
- Goldman initiated coverage on Ascendis Pharma with a new price targetGoldman initiated coverage of Ascendis Pharma with a rating of Buy and set a new price target of $174.00
- Citigroup initiated coverage on Ascendis Pharma with a new price targetCitigroup initiated coverage of Ascendis Pharma with a rating of Buy and set a new price target of $187.00
- Cowen initiated coverage on Ascendis Pharma with a new price targetCowen initiated coverage of Ascendis Pharma with a rating of Market Perform and set a new price target of $136.00
- Wells Fargo initiated coverage on Ascendis Pharma with a new price targetWells Fargo initiated coverage of Ascendis Pharma with a rating of Overweight and set a new price target of $176.00
- Stifel Nicolaus initiated coverage on Ascendis Pharma A/SStifel Nicolaus initiated coverage of Ascendis Pharma A/S with a rating of Buy